‘Predis’ is an AI-based early warning system that detects anomalies and irregularities by performing advanced data analysis, including predictive analytics, time series analysis and anomaly detection, on drug movements within Türkiye’s nationwide pharmaceutical supply chain. The system analyzes data from the Pharmaceutical Track andTrace System (İTS), involving over 60,000 stakeholders (manufacturers/exporters, warehouses, pharmacies, consumption centers), to provide insights on regional epidemic risks, disease trends, anomalies in drug consumption and prescriptions and fraud/parallel trade detection.

The project's main objectives are to enhance the transparency and security of the pharmaceutical supply chain, safeguard public health and ensure sustainable access to medications by empowering the Turkish Medicines & Medical Devices Agency (TİTCK). It enables the agency to detect anomalies, prevent disruptions in medication supply and support the Ministry of Health in monitoring regional health trends for timely interventions.

Achieved results include strengthening oversight capabilities and enhancing supply chain resilience. By improving the monitoring of antibiotics, psychotropics and narcotic drugs, 'Predis' supported the development of policies like "Rational Drug Use" and enabled data-driven public health strategies.

The project’s impacts include a secure pharmaceutical supply chain, equitable medication distribution, and tools for monitoring health trends, ensuring effective responses to epidemic risks and advancing a data-driven healthcare system in Türkiye.

https://www.tigahealth.com/p/predis/

• Türkiye (Republic of)

• Youth
• Older persons
• Women
• Indigenous and nomadic peoples
• People with disabilities
• The unemployed
• The poor
• Migrants
• Refugees and internally displaced people
• Remote and rural communities

‘Predis’ is a highly replicable system. It is currently able to track the movement of pharmaceuticals in the supply chain using data from the Pharmaceutical Track and Trace System (İTS) in Türkiye, but the scope of its operation can be expanded. It can be implemented in any country using a pharmaceutical track and trace system or can be integrated across health sectors using different data sets in the healthcare context. Additionally, ‘Predis’ is not limited to nationwide applications; it is equally suitable for use in regional pharmaceutical tracking systems or states where decentralized monitoring frameworks are in place. Its scalable architecture allows it to meet the diverse regulatory needs of different regions, making it suitable for deployment in multiple countries and regions. Moreover, ‘Predis’ can be adapted to various healthcare environments beyond pharmaceutical tracking. Utilizing different advanced AI algorithms, it has the potential to leverage disease-diagnosis-treatment data, enabling broader applications to enhance healthcare delivery and improve patient outcomes. Its integration with existing IT infrastructure, including electronic health records (EHR) and supply chain management systems, also enhances its replicability. The system has the capacity to perform data analysis tailored to the specific type of data it processes, regardless of whether the data is related to drug tracking or healthcare services. It can be utilized in areas such as monitoring patient outcomes, tracking disease spread and identifying potential epidemic risks.

The sustainability of ‘Predis’ stems from its paperless, online-based implementation, which minimizes administrative costs and reduces environmental impact. By leveraging advanced AI-driven insights to optimize pharmaceutical monitoring, the system not only reduces redundant drug shipments but also prevents stock shortages and overstocking, ensuring a balanced supply chain that minimizes waste and improves resource allocation. Additionally, it supports the rational use of medications by providing data-driven tools for monitoring drug consumption patterns, reducing unnecessary prescriptions, and promoting evidence-based interventions.

The system's real-time anomaly detection minimizes losses from fraud and expired medications, contributing to economic and environmental sustainability. ‘Predis’ improves operational efficiency by reducing unnecessary logistics movements, lowers resource consumption and reduces the healthcare system's carbon footprint. Decision-makers benefit from real-time notifications, which enables prompt actions and informed resource management. Through these capabilities, ‘Predis’ supports a greener, more cost-effective and sustainable healthcare ecosystem, positioning it as a critical tool for the future of healthcare.

Through its generic medicine module, ‘Predis’ identifies cost-effective alternatives, which not only reduce healthcare costs for public and reimbursement institutions but also prevent excessive spending on medications for patients. This supports a more sustainable approach to medicine distribution by promoting the use of affordable, equally effective options, ultimately lowering environmental impact and ensuring the efficient use of available healthcare resources. It also integrates seamlessly with existing IT infrastructure, ensuring sustainable information management. As a result, 'Predis' offers a future-proof, environmentally friendly solution for drug safety, supply chain tracking, and drug accessibility.

‘Predis’ aligns with several key WSIS Action Lines, promoting digital inclusion, transparency and sustainability in healthcare. Through the use of ICTs, it improves healthcare (C7), ensures safety and traceability of medicines and prevents counterfeit drugs. The system addresses inequalities in access to medicines. This ensures that patients have access to the affordable medicines they need, while preventing stock-outs. For regulatory bodies such as Ministry of Health and TİTCK, risk management, appropriate resource allocation and management and public health management can be carried out. It prevents irregularities and fraud, ensures the implementation of public health policies such as rational drug use and prevents the abuse of narcotic drugs. ‘Predis’ also emphasizes the role of public governance authorities and stakeholders (C1) by fostering collaboration among regulators, healthcare providers and the public, creating a unified approach to leveraging ICTs for better healthcare outcomes. Furthermore, the system actively supports capacity building (C4) by equipping healthcare professionals and organizations with the resources and knowledge to ensure the utilization and adoption of digital health technologies. ‘Predis’ enhances trust and security in ICTs (C5) by providing a transparent, reliable digital framework for healthcare. Through secure data exchange, regulatory compliance, and innovation, it supports a conducive environment for investment and community development in digital health. Since ‘Predis’ utilizes pharmaceutical tracking (İTS) and e-Prescription data, citizens can access detailed information about their medications—such as availability in specific pharmacies, drug details and prices—through the publicly available İTS Mobile application. It also strengthens the communication infrastructure for all stakeholders in the pharma ecosystem (C2) by ensuring seamless data integration and improving healthcare accessibility.